Latest Breaking News On - டைவாந் வணிக விரைவான - Page 3 : comparemela.com
Taiwan Business Quick Take - Taipei Times
taipeitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taipeitimes.com Daily Mail and Mail on Sunday newspapers.
Taiwan Business Quick Take - Taipei Times
taipeitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taipeitimes.com Daily Mail and Mail on Sunday newspapers.
Taiwan Business Quick Take - Taipei Times
taipeitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taipeitimes.com Daily Mail and Mail on Sunday newspapers.
EQUITIES
<strong>Virus worries impact TAIEX</strong>
The TAIEX yesterday moved lower to close below 17,000 points, as investors’ concerns over a surge in domestic COVID-19 cases continued. Selling focused on large-cap tech stocks, while cyclical old economy stocks also came under pressure later in the session as investors locked in gains posted in previous sessions, dealers said. The TAIEX ended down 109.99 points, or 0.64 percent, at 16,966.22, while turnover totaled NT$398.405 billion (US$14.348 billion), up from NT$350.72 billion the previous day. Foreign institutional investors sold a net NT$14.97 billion of shares on the market yesterday, Taiwan Stock Exchange data showed. ELECTRONICS
<strong>Innolux profit
Taiwan Business Quick Take
Adimmune plans expansion
Vaccine maker Adimmune Corp (國光生技) and its subsidiary Enimmune Corp (安特羅生技) on Tuesday signed a memorandum of understanding with Singapore-listed Innovalues Tech for a joint venture in Southeast Asia to explore local markets. Innovalues Tech is a subsidiary of private equity group Northstar (北極星), with capital of US$350 million. Innovalues Tech has positioned itself as a provider of biomedicine-related products and has invested in several medical centers in Singapore, Indonesia and Malaysia. The joint venture is expected to be established before the end of the year, with the initial goal of introducing influenza, tetanus and enterovirus vaccines to Southeast Asian markets, Adimmune said in a statement. The new company would later expand its product line to COVID-19 vaccines, it said. An overseas joint venture would facilitate clinical trials, drug permit applications and marketing of its products locally, A